Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Parkinson’s Disease Therapeutics: Emphasis on Nanotechnological Advances presents the latest information on the second most common neurodegenerative disorder in the elderly. Despite remarkable progress in various PD therapeutics, such as microRNAs and brain drug delivery systems, a few limitations impede their success. This book sheds light on the pros and cons of recently developed novel therapeutics. Very few books have highlighted the protective efficacy of natural products, antioxidants, and biomaterial design for other diseases.
- Emphasizes novel therapeutics for Parkinson’s disease, including nanotechnology, natural products and antioxidants
- Discusses the pros and cons of recently developed therapy options for Parkinson's
- Focuses on the efficacy of nanotechnology in overcoming the blood-brain barrier and biomaterial design
Neuroscientists, biomedical researchers and graduate and medical students
1. Introduction: Parkinson’s Disease Pathology and Therapeutics
2. Biomaterials: A Boon or a Bane in the Treatment of Parkinson’s Disease
3. Blood Brain Barrier
4. Natural Compounds in the Treatment of Parkinson’s Disease
5. Curcumin: A Promising Therapeutic in Parkinson’s Disease Treatment
6. Redox Nanoparticles: The Corner Stones in the Development of Parkinson’s Disease Therapeutics
7. Liposomal Maneuvers against Parkinson’s Disease
8. Nasal Delivery Nanoparticles: An Insight into Novel Parkinson’s Disease Therapeutics
9. α-Synuclein Targeted Nanoparticles
10. Pros and Cons of Parkinson’s Disease Therapeutics
- No. of pages:
- © Academic Press 2020
- 3rd February 2020
- Academic Press
- Paperback ISBN:
- eBook ISBN:
M. Obulesu is a Scientist in ATG Laboratories, Pune, India. He has 19 years of research and teaching experience. His research areas are multifarious which include food science, pathology of Neurodegenerative diseases such as Alzheimer’s disease and designing polymer based Biomaterials (Design of hydrogels etc.). He did Alzheimer’s disease research and developed an aluminium induced neurotoxicity rabbit model. His present research focuses on development of redox-active injectable hydrogels of polyion complex. His research area also includes development of metal chelators to overcome metal induced toxicity. His books, 3 monographs entitled “Alzheimer’s Disease Theranostics (Elsevier (First Edition))” “Parkinson’s Disease Therapeutics: Emphasis on Nanotechnological Advances” (Elsevier (First Edition)), “Turmeric and Curcumin for Neurodegenerative Diseases (Elsevier (First Edition))” and an editorial collection “Phytomedicine and Alzheimer’s Disease (Taylor and Francis (First Edition))” are accepted currently. He is the first and corresponding author for majority of his articles. He secured a certificate from Stanford University for the Scientific Writing course. He is on editorial board of a few pathology journals such as Journal of Medical Laboratory and Diagnosis, Journal of Medical and Surgical Pathology, Annals of Retrovirals and Antiretrovirals, Kenkyu Journal of Medical Science and Clinical Research, SciFed Oncology and Cancer Research Journal, Journal of Cancer and Cure. He is also on editorial board of nanotechnology journals such as SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science.
Scientist, ATG Laboratories, Pune, India, Certified by Stanford University for Scientific Writing
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.